ETC
RGNX icon

Exchange Traded Concepts’s Regenxbio RGNX Stock Holding History

Exchange Traded Concepts’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33,886
Closed -$677K – 1471
2023
Q2 		$677K Hold
33,886
– – 0.02% 492
2023
Q1 		$641K Buy
+33,886
New +$750K 0.02% 457

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Exchange Traded Concepts's RGNX Position: Q3 2023 in Review

Exchange Traded Concepts sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 33,886 shares — an estimated $677K sold.

Exchange Traded Concepts first reported a position in RGNX in Q1 2023 and held it in 2 quarters. The position peaked at $677K in Q2 2023. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Exchange Traded Concepts reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 33,886 Regenxbio shares in Q3 2023, an estimated $677K.
  • Exchange Traded Concepts first reported a position in Regenxbio in Q1 2023 and held it in 2 quarters.
  • Exchange Traded Concepts's Regenxbio position peaked at $677K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Exchange Traded Concepts's 13F filing for Q3 2023, filed 18 Oct 2023.